- Home
- CHR vs SABS Comparison
CHR vs SABS Comparison
Compare CHR & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHR
- SABS
- Stock Information
- Founded
- CHR 2016
- SABS 2014
- Country
- CHR China
- SABS United States
- Employees
- CHR N/A
- SABS N/A
- Industry
- CHR EDP Services
- SABS Biotechnology: Pharmaceutical Preparations
- Sector
- CHR Technology
- SABS Health Care
- Exchange
- CHR Nasdaq
- SABS Nasdaq
- Market Cap
- CHR 13.3M
- SABS 15.8M
- IPO Year
- CHR N/A
- SABS N/A
- Fundamental
- Price
- CHR $0.18
- SABS $2.34
- Analyst Decision
- CHR
- SABS Strong Buy
- Analyst Count
- CHR 0
- SABS 4
- Target Price
- CHR N/A
- SABS $9.50
- AVG Volume (30 Days)
- CHR 30.0M
- SABS 481.4K
- Earning Date
- CHR 07-30-2025
- SABS 11-05-2025
- Dividend Yield
- CHR N/A
- SABS N/A
- EPS Growth
- CHR N/A
- SABS N/A
- EPS
- CHR 1.92
- SABS N/A
- Revenue
- CHR $147,134,000.00
- SABS $114,698.00
- Revenue This Year
- CHR N/A
- SABS N/A
- Revenue Next Year
- CHR N/A
- SABS N/A
- P/E Ratio
- CHR $0.08
- SABS N/A
- Revenue Growth
- CHR N/A
- SABS N/A
- 52 Week Low
- CHR $0.12
- SABS $1.00
- 52 Week High
- CHR $3.45
- SABS $6.60
- Technical
- Relative Strength Index (RSI)
- CHR 22.68
- SABS 55.11
- Support Level
- CHR $0.16
- SABS $1.85
- Resistance Level
- CHR $0.19
- SABS $2.49
- Average True Range (ATR)
- CHR 0.05
- SABS 0.21
- MACD
- CHR -0.04
- SABS 0.01
- Stochastic Oscillator
- CHR 8.76
- SABS 47.00
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.